BCL6B and hepatocellular carcinoma: These results were confirmed in TMAs from 90 HCC patients, which showed a significant decrease in BCL6B expression in 69 of 90 HCC tissue samples (76.7%) compared with matched normal liver tissues (p < 0.001; Figure 1D, 1E).